Executive Chairman · IONIS PHARMACEUTICALS INC (IONS)

Stanley Crooke

A named executive officer of IONIS PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$9,486,529

Salary $683,630Stock awards $3,908,663Bonus $587,665

FY2019: $9,598,830

2nd of 6 named executive officers at Ionis Pharmaceuticals by FY2020 total.

6 named officers on file for IONIS PHARMACEUTICALS, FY2020

Stanley Crooke’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • IONS’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IONIS PHARMACEUTICALS’s whole pay program stands against its peers

  • IONIS PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IONS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2021 (DEF 14A).

Free

Get Stanley Crooke’s full pay file as a PDF — free

More than this page: up to 10 years of Stanley’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Stanley Crooke compensation by year

IONIS PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held
In US dollars, as IONIS PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$824,535$849,271$883,242$911,506$683,630
Bonus$1,205,882$1,006,068$759,257$925,748$587,665
Stock awards$1,427,416$1,306,509$1,870,630$3,712,677$3,908,663
Option awards$5,705,552$4,113,250$4,073,394$3,911,301$4,267,239
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$25,366$39,554$39,056$137,598$39,332
Total$9,188,751$7,314,652$7,625,579$9,598,830$9,486,529

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IONIS PHARMACEUTICALS INC DEF 14A filed April 23, 2021, accession 0001140361-21-013999, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IONIS PHARMACEUTICALS INC filed document, accession 0001140361-21-013999. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2021.

$9.2M
$7.3M
$7.6M
$9.6M
$9.5M
FY16
FY17
FY18
FY19
FY20
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU62,982$3,561,002—
RSU47,794$2,702,273—
RSU17,574$993,634—
RSU6,792$384,020—
Option3,397—$47.34
Option42,839—$49.25
Option74,688—$53.77
Option141,709—$60.89

Per the Outstanding Equity Awards at Fiscal Year-End table in IONIS PHARMACEUTICALS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

IONIS PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Brett MoniaPresident, Chief Executive Officer$10,963,040
Stanley Crooke · this pageExecutive Chairman$9,486,529
Elizabeth HougenExecutive Vice President, Finance and Chief Financial Officer$4,341,100
Richard GearyExecutive Vice President, Chief Development Officer$4,011,036
Patrick O’NeilExecutive Vice President, Legal, General Counsel and Corporate Secretary$3,965,065
Onaiza Cadoret-ManierExecutive Vice President, Chief Global Product Strategy and Operations Officer$3,504,442

Board service

IONIS PHARMACEUTICALS board · FY2021
Director compensation in US dollars, as IONIS PHARMACEUTICALS reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2021$683,630$326,806$313,853$272,569$1,596,858

Each year as the company reported it in IONIS PHARMACEUTICALS's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: IONIS PHARMACEUTICALS pays directors a $60,000 cash retainer and $450,000 in Options and RSUs. As stated in IONIS PHARMACEUTICALS's FY2025 proxy.

The full IONIS PHARMACEUTICALS compensation record

free company brief

This page is one person within IONIS PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IONIS PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IONIS PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stanley Crooke's compensation dossier · One-time report. No refunds.